No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
376 |
4. Check minimum number of eventsNone |
376 |
5. Include endpointsNone |
376 |
6. Filter based on genotype QC (FinnGen only) |
376 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M67
- Name in latin
- Hypertrophia membranae synovialis non alibi classificata
Similar endpoints
↥List of similar endpoints to Synovial hypertrophy, not elsewhere classified based on the number of shared cases.
Similar with more cases:
- Disorders of synovium and tendon
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 3056 | 1552 | 1498 |
Only index persons | 3008 | 1538 | 1470 |
Unadjusted period prevalence (%) | |||
Whole population | 0.04 | 0.04 | 0.04 |
Only index persons | 0.06 | 0.06 | 0.06 |
Median age at first event (years) | |||
Whole population | 36.05 | 35.31 | 36.81 |
Only index persons | 36.00 | 35.29 | 36.74 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 376 | 221 | 155 |
Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.07 |
Median age at first event (years) | 38.14 | 36.49 | 40.48 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 343
- Matched controls
- 3430
LabWAS
↥Mortality – FinRegistry
↥Association
Association between endpoint M13_SYNOHYPERTROPH and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
M13_SYNOHYPERTROPH | 0.855 [0.66, 1.11] | 0.242 |
Birth year | 0.99 [0.98, 1.0] | 0.031 |
During the follow-up period (1.1.1998 — 31.12.2019), 52 out of 1348 females with M13_SYNOHYPERTROPH died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
M13_SYNOHYPERTROPH | 0.647 [0.51, 0.83] | < 0.001 |
Birth year | 0.989 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 65 out of 1281 males with M13_SYNOHYPERTROPH died.
Mortality risk
Mortality risk for people of age
years, who have M13_SYNOHYPERTROPH.N-year risk | Females | Males |
---|---|---|
1 | 0.068% | 0.126% |
5 | 0.399% | 0.722% |
10 | 0.962% | 1.892% |
15 | 1.923% | 3.781% |
20 | 3.398% | 6.383% |
Relationships between endpoints
↥Index endpoint: M13_SYNOHYPERTROPH – Synovial hypertrophy, not elsewhere classified
GWS hits: -